Cargando…
The neuropsychiatric complications of stimulant abuse /
This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on the neuropsychiatric complications of stimulant abuse.<br><br><ul><li>Brings together c...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Waltham, MA :
Academic Press,
2015.
|
| Edición: | First edition. |
| Colección: | International review of neurobiology ;
v. 120. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn911032844 | ||
| 003 | OCoLC | ||
| 005 | 20231120112004.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 150615s2015 maua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OPELS |d OCLCO |d N$T |d OCLCO |d YDXCP |d IDEBK |d CDX |d OCLCF |d OCLCO |d RTH |d OCLCQ |d DEBBG |d OHS |d OCLCO |d CUS |d D6H |d AU@ |d OCLCA |d UKMGB |d OCLCO |d OCLCA |d OCLCQ |d OCL |d OCLCO | ||
| 015 | |a GBB565931 |2 bnb | ||
| 016 | 7 | |a 017367629 |2 Uk | |
| 020 | |a 9780128030035 |q electronic bk. | ||
| 020 | |a 0128030038 |q electronic bk. | ||
| 020 | |z 9780128029787 | ||
| 035 | |a (OCoLC)911032844 | ||
| 050 | 4 | |a RC564 | |
| 072 | 7 | |a HEA |x 010000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 012000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 020000 |2 bisacsh | |
| 072 | 7 | |a MED |x 076000 |2 bisacsh | |
| 082 | 0 | 4 | |a 613.8/4 |2 23 |
| 245 | 0 | 4 | |a The neuropsychiatric complications of stimulant abuse / |c [edited by] Pille Taba (Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia) , Andrew John Lees (The National Hospital, Queen Square, London, United Kingdom), Katrin Sikk (Department of Neurology, North-Estonian Regional Hospital, Tallinn, Estonia]. |
| 250 | |a First edition. | ||
| 264 | 1 | |a Waltham, MA : |b Academic Press, |c 2015. | |
| 300 | |a 1 online resource : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a International review of neurobiology ; |v volume 120 | |
| 500 | |a Includes index. | ||
| 588 | 0 | |a Online resource; title from title details screen (ScienceDirect, viewed June 18, 2015). | |
| 505 | 0 | |a Front Cover; The Neuropsychiatric Complications of Stimulant Abuse; Copyright; Contents; Contributors; Chapter One: The Story of ��Speed�� from ��Cloud Nine�� to Brain Gain; References; Chapter Two: Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses; 1. Introduction; 2. Early History of the Amphetamines; 3. Wakefulness, Attention, and Cognitive Performance; 4. Mood Elevation; 5. Appetite Suppression; 6. Military Use: ��Combat Fatigue�� and the Second World War; 7. Nonmedical Use, Abuse, and Dependence; 8. Conclusion; Acknowledgment; References. | |
| 505 | 8 | |a Chapter Three: Miracle or Menace?References; Chapter Four: Psychostimulants: Basic and Clinical Pharmacology; 1. Introduction; 2. Human and Animal Effects of Psychostimulants; 3. Chemistry and Pharmacology of Psychostimulants; 4. Psychostimulant Use Versus Abuse; 4.1. Improved Social Interaction; 4.2. Facilitated Sexual Behavior; 4.3. Improved Cognitive Performance and Counteracting Fatigue; 4.4. Facilitated Recovery and Coping with Psychological Stress; 4.5. Sensory Curiosity-Expanded Perception Horizon and Boredom; 4.6. Euphoria, Hedonia, and High. | |
| 505 | 8 | |a 5. Strategies for the Treatment of Psychostimulant Use Disorder: Clinical and Nonclinical Approaches, Evolving Targets5.1. Pharmacological Strategies; 5.1.1. Dopamine-Based Strategies; 5.1.1.1. l-DOPA; 5.1.1.2. Dexamphetamine; 5.1.1.3. Methylphenidate; 5.1.1.4. Selegiline; 5.1.1.5. Bupropion; 5.1.1.6. Modafinil; 5.1.1.7. Disulfiram; 5.1.1.8. Antipsychotics; 5.1.2. 5-HT-Based Strategies; 5.1.3. GABA-Based Strategies; 5.1.3.1. Gabapentin; 5.1.3.2. Tiagabine; 5.1.3.3. Vigabatrin; 5.1.3.4. Baclofen; 5.1.4. Glutamate-Based Strategies; 5.1.4.1. Ketamine; 5.1.4.2. Memantine. | |
| 505 | 8 | |a 5.1.4.3. N-Acetylcysteine5.1.5. ��Other�� Target-Based Strategies; 5.1.5.1. Acamprosate; 5.1.5.2. Galantamine; 5.1.5.3. Naltrexone; 5.1.5.4. Varenicline; 5.2. Pharmacokinetic/Immuno Strategies; 6. Concluding Remarks; References; Chapter Five: Epigenetic Mechanisms of Psychostimulant-Induced Addiction; 1. Introduction; 2. Epigenetic Processes; 3. Chromatin Structure; 4. Histone Modifications; 4.1. Histone Code; 5. DNA Methylation and Demethylation; 6. Noncoding RNA; 7. Epigenetic Mechanisms in Psychostimulant-Induced Addiction. | |
| 505 | 8 | |a 7.1. Role of Histone Modifications in Psychostimulant-Induced Addiction7.1.1. Histone Acetylation; 7.1.2. Histone Methylation; 7.1.3. Histone Phosphorylation; 7.2. Role of DNA Methylation in Psychostimulant-Induced Addiction; 7.3. Role of Noncoding RNAs in Addiction; 8. Conclusions; References; Chapter Six: Experimental Models on Effects of Psychostimulants; 1. Introduction; 2. Changes in the Brain in Response to Psychostimulants; 3. Animal Models; 4. Psychostimulant Animal Models; 5. Animal Models to Analyze Reinforcing Properties; 5.1. Intravenous Drug Self-Administration. | |
| 520 | |a This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on the neuropsychiatric complications of stimulant abuse.<br><br><ul><li>Brings together cutting-edge research on the neuropsychiatric complications of stimulant abuse</li></ul> <ul><li>Emerging topics: stimulants, amphetamines, legal highs, designer drugs, neuropsychiatric complications.</li></ul> | ||
| 650 | 0 | |a Stimulants. | |
| 650 | 0 | |a Drug abuse |x Psychological aspects. | |
| 650 | 0 | |a Behavioral toxicology. | |
| 650 | 0 | |a Neurobehavioral disorders. | |
| 650 | 0 | |a Drug abuse. | |
| 650 | 0 | |a Drug addiction. | |
| 650 | 2 | |a Substance-Related Disorders |0 (DNLM)D019966 | |
| 650 | 2 | |a Neurocognitive Disorders |0 (DNLM)D019965 | |
| 650 | 6 | |a Stimulants. |0 (CaQQLa)201-0054158 | |
| 650 | 6 | |a Toxicomanie |0 (CaQQLa)201-0014203 |x Aspect psychologique. |0 (CaQQLa)201-0373794 | |
| 650 | 6 | |a Toxicologie du comportement. |0 (CaQQLa)201-0090888 | |
| 650 | 6 | |a Troubles neurocognitifs. |0 (CaQQLa)201-0304278 | |
| 650 | 6 | |a Toxicomanie. |0 (CaQQLa)201-0014203 | |
| 650 | 7 | |a drug abuse. |2 aat |0 (CStmoGRI)aat300189237 | |
| 650 | 7 | |a drug addiction. |2 aat |0 (CStmoGRI)aat300189207 | |
| 650 | 7 | |a HEALTH & FITNESS / Healthy Living |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Holism |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Reference |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Preventive Medicine |2 bisacsh | |
| 650 | 7 | |a Drug addiction |2 fast |0 (OCoLC)fst01430217 | |
| 650 | 7 | |a Drug abuse |2 fast |0 (OCoLC)fst00898480 | |
| 650 | 7 | |a Behavioral toxicology |2 fast |0 (OCoLC)fst00829952 | |
| 650 | 7 | |a Drug abuse |x Psychological aspects |2 fast |0 (OCoLC)fst00898548 | |
| 650 | 7 | |a Neurobehavioral disorders |2 fast |0 (OCoLC)fst01036314 | |
| 650 | 7 | |a Stimulants |2 fast |0 (OCoLC)fst01133448 | |
| 700 | 1 | |a Taba, Pille, |e editor. | |
| 700 | 1 | |a Lees, Andrew, |d 1947- |e editor. | |
| 700 | 1 | |a Sikk, Katrin, |e editor. | |
| 776 | 0 | 8 | |i Print version: |z 9780128029787 |
| 830 | 0 | |a International review of neurobiology ; |v v. 120. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128029787 |z Texto completo |